Astellas US LLC et al v. Sandoz Inc.
| Gilead Sciences, Inc., Astellas US LLC and Astellas Pharma US, Inc. |
| Sandoz Inc. |
| 1:2018cv01676 |
| October 25, 2018 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 21, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 16 ANSWER to #13 Answer to Complaint, Counterclaim by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Fahnestock, Derek) |
| Pro Hac Vice Attorney Charles T. Cox, Jr. and Amy K. Wigmore for Astellas Pharma US, Inc. and Astellas US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(ceg) |
| Pro Hac Vice Attorney Brittany B. Amadi and Kevin M. Yurkerwich for Astellas Pharma US, Inc. and Astellas US LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(ceg) |
Filing 15
ORDER, IT IS ORDERED that, on or before December 27, 2018, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 12/27/2018.) Signed by Judge Colm F. Connolly on 12/11/2018. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(nmf)
|
| Pro Hac Vice Attorney Lisa M. Ferri for Gilead Sciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(crb) |
| Pro Hac Vice Attorney Manuel J. Velez for Gilead Sciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-01678-CFC, 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC(crb) |
|
SO ORDERED, re (15 in 1:18-cv-01678-CFC, 12 in 1:18-cv-01676-CFC, 12 in 1:18-cv-01677-CFC, 12 in 1:18-cv-01675-CFC) MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Tracey C. Allen, Brittany Amadi, Charles T. Cox, Jr., Robert M. Galvin and Kevin M. Yurkerwich filed by Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 12/3/2018. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(fms)
|
| Filing 14 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) |
| Filing 13 ANSWER to #1 Complaint, with Jury Demand , COUNTERCLAIM against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. by Sandoz Inc..(Gattuso, Dominick) |
| Filing 12 MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Tracey C. Allen, Brittany Amadi, Charles T. Cox, Jr., Robert M. Galvin and Kevin M. Yurkerwich - filed by Astellas Pharma US, Inc., Astellas US LLC. (Fahnestock, Derek) |
| CORRECTING ENTRY: The docket text of the Motion for Pro Hac Vice Appearance of Lisa M. Ferri and Manuel J. Velez has been corrected to reflect that the motion is only filed on behalf of Gilead Sciences, Inc. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(fms) |
|
SO ORDERED, re (11 in 1:18-cv-01676-CFC, 11 in 1:18-cv-01677-CFC, 11 in 1:18-cv-01675-CFC, 14 in 1:18-cv-01678-CFC) MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri and Manuel J. Velez filed by Gilead Sciences, Inc., Signed by Judge Colm F. Connolly on 11/26/2018. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC(fms) Modified on 11/26/2018 (fms).
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri and Manuel J. Velez - filed by Gilead Sciences, Inc. (Fahnestock, Derek) Modified on 11/26/2018 (fms). |
| Filing 10 STIPULATION TO EXTEND TIME [Proposed] Order to Answer Complaint (D.I. 1) to November 30, 2018 - filed by Sandoz Inc.. (Gattuso, Dominick) |
| Filing 9 NOTICE of Appearance by Dominick T. Gattuso on behalf of Sandoz Inc. (Gattuso, Dominick) |
|
SO ORDERED, re #10 STIPULATION TO EXTEND TIME [Proposed] Order to Answer Complaint (D.I. 1) to November 30, 2018 filed by Sandoz Inc., Set/Reset Answer Deadlines: Sandoz Inc. answer due 11/30/2018. Signed by Judge Colm F. Connolly on 11/14/2018. (fms)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:18-cv-01675-CFC, 1:18-cv-01676-CFC, 1:18-cv-01677-CFC, 1:18-cv-01678-CFC (rjb) |
| Filing 8 DECLARATION of Mailing (as to service on Sandoz Inc.) by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Fahnestock, Derek) |
| Filing 7 SUMMONS Returned Executed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. Sandoz Inc. served on 10/26/2018, answer due 11/16/2018. (Fahnestock, Derek) |
| Summons Issued with Magistrate Consent Notice attached as to Sandoz Inc. on 10/26/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas Pharma Inc., Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,106,183 ;9,085,601. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: SEE ATTACHED. Date of Expiration of Patent: 2/2/2027. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGMENT filed against Sandoz Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2489815.) - filed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
